Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 7, keine Gesamtzahl für „Interactions“
Suchtreffer
Begriffe & Kennungen
Briviact (in Italy: Nubriveo) · 4.5 · Potential interactions between brivaracetam (50 mg/day to 200 mg/day) and other AEDs were investigated in a po
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.5 · Potential interactions between brivaracetam (50 mg/day to 200 mg/day) and other AEDs were investigated in a po
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.5 · Potential interactions between brivaracetam (50 mg/day to 200 mg/day) and other AEDs were investigated in a po
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.5 · Table 1: Pharmacokinetic interactions between brivaracetam and other AEDs AED coadministered Influence of AED
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.5 · Table 1: Pharmacokinetic interactions between brivaracetam and other AEDs AED coadministered Influence of AED
Eintrag öffnenBuccolam · 4.5 · Medicinal product interactions following oromucosal administration of midazolam are likely to be similar to th
Eintrag öffnenBuccolam · 4.5 · Pharmacodynamic Drug-Drug Interactions (DDI)
Eintrag öffnenCamzyos · 4.5 · 9 Pharmacokinetic interactions
Eintrag öffnenCamzyos · 4.5 · Pharmacodynamic interactions
Eintrag öffnenCapecitabine Accord · 4.5 · Allopurinol Interactions with allopurinol have been observed for 5-FU; with possible decreased efficacy of 5-F
Eintrag öffnenCapecitabine Teva · 4.5 · Allopurinol Interactions with allopurinol have been observed for 5-FU; with possible decreased efficacy of 5-F
Eintrag öffnenCavoley · 4.5 · Possible interactions with other haematopoietic growth factors and cytokines have not been specifically invest
Eintrag öffnenCayston · 4.5 · No interaction studies have been performed. However, no evidence of any drug interactions with aztreonam were
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.5 · Possible interactions with other haematopoietic growth factors and cytokines have not been specifically invest
Eintrag öffnenCelsentri · 4.5 · 34 Table 2: Interactions and adulta dose recommendations with other medicinal products
Eintrag öffnenCelsentri · 4.5 · 7 Table 2: Interactions and adulta dose recommendations with other medicinal products
Eintrag öffnenCeprotin · 4.5 · No interactions with other medicinal products are currently known.
Eintrag öffnenCeprotin · 4.5 · No interactions with other medicinal products are currently known.
Eintrag öffnenCholib · 4.5 · Interactions relevant to monotherapies Inhibitors of CYP 3A4 Simvastatin is a substrate of cytochrome P450 3A4
Eintrag öffnenCholib · 4.5 · Interactions relevant to monotherapies Inhibitors of CYP 3A4 Simvastatin is a substrate of cytochrome P450 3A4
Eintrag öffnen